Purdue Institute for Drug Discovery

FAP-PI3Ki

Overview: 

Fibroblast activation protein alpha (FAP) targeted PI3K inhibitors for the treatment of cancer.

Status: 

Purdue Faculty: 

Dr. Philip Low

Development Partner: 

Umoja Biopharma